Skip to main content
. 2019 Feb 12;10:211. doi: 10.3389/fmicb.2019.00211

Table 1.

Antibiotic susceptibility profiles of ESBL-producing K. pneumoniae of isolates from river water (RW), rivers sediment (RS), pig manure (PM), soil (S), and vegetables (V).

Isolate Source MIC (mg/L)a
CL AMC TZP CTX CAZ MEM ETP IPM GEN AMK TE TGC CIP SXT FOF F FFC
KP1 RW 0.125 16 32 2 2 0.015 0.015 0.25 32 4 128 2 16 >16 256 256 >32
KP2 RW 0.06 16 256 8 0.5 0.03 0.06 0.125 32 8 128 2 16 >16 256 512 >32
KP3 RW 0.125 16 128 8 16 0.015 0.015 0.06 32 2 128 2 0.5 >16 128 256 4
KP4 RW 0.125 32 256 32 1 0.015 0.015 0.125 128 2 64 2 8 8 >256 256 >32
KP5 RW 0.125 32 256 >32 1 0.03 0.015 0.125 1 2 128 2 1 8 >256 256 8
KP6 RW 0.125 32 256 >32 1 0.015 0.03 0.125 64 4 128 4 16 8 256 256 >32
KP7 PM 0125 16 256 8 0.5 0.015 0.06 0.125 32 4 128 2 16 >16 256 256 >32
KP8 PM 0.125 16 4 8 1 0.015 0.015 0.125 16 2 128 1 4 8 256 128 32
KP9 S 0.125 32 256 4 1 0.015 0.03 0.125 64 4 128 2 8 8 512 256 >32
KP10 S 0.06 32 256 >32 1 0.015 0.05 0.125 64 2 128 4 0.5 8 >256 64 2
KP11 V 0.125 16 256 8 1 0.015 0.015 0.125 16 2 128 1 1 >16 256 64 >32
KP12 V 0.06 32 256 >32 1 0.03 0.03 0.125 >128 8 128 2 4 8 >256 256 >32
KP13 RS 0.125 16 256 8 0.5 0.015 0.06 0.125 32 4 128 0.5 16 >16 256 128 >32
KP14 WW 0.125 16 256 8 1 0.015 0.03 0.06 32 4 128 1 16 >16 256 512 >32

Resistance is indicated in bold and intermediate is indicated in underlined.

a

MICs were determined by agar dilution methods for all antibiotics except for colistin, for which broth microdilution was used. Resistance is indicated in bold. CL, colistin; AMC, amoxicillin/clavulanate; TZP, piperacillin/tazobactam; CTX, cefotaxime; CAZ, ceftazidime; MEM, meropenem; GEN, gentamicin; AMK, amikacin; TE, tetracycline; TGC, tigecycline, CIP, ciprofloxacin; SXT, trimethoprim/sulfamethoxazole; FOF, fosfomycin; F, nitrofurantoin; FFC, florfenicol. Antimicrobial susceptibility profiles were determined using clinical breakpoints recommended by the EUCAST criteria (http://www.eucast.org/clinical_breakpoints/), except for tetracycline and nitrofurantion, for which the Clinical and Laboratory Standards Institute (CLSI, 2017) breakpoints were used, and florfenicol, for which a resistance breakpoint of >16 mg/L, based on the epidemiological cut-off values for the closely related Escherichia coli and Salmonella spp. available at EUCAST, was used.